This site is intended for healthcare professionals only
LoginRegister

Oncology Dialogues

AstraZeneca-Amgen Tezspire gets USFDA nod for chronic rhinosinusitis with nasal polyps

USFDA grants priority review to AstraZeneca-Daiichi Sankyo Enhertu for HER2-low, HER2 Ultralow...

AstraZeneca and Daiichi Sankyo's supplemental Biologics License Application (sBLA) for Enhertu (trastuzumab deruxtecan) has been accepted and...
View All

Latest News and Guidelines

High Accuracy Ultrasound May Identify 96 Percent of Postmenopausal Women with Ovarian Cancer: Lancet Oncology Study

High Accuracy Ultrasound May Identify 96 Percent of Postmenopausal Women with Ovarian Cancer: Lancet...

MRI provides early warning system for glioblastoma growth, finds Sylvester study

MRI provides early warning system for glioblastoma growth, finds Sylvester study

IMRT and proton therapy offer equally high QoL and tumor control for people with prostate cancer, reports study

IMRT and proton therapy offer equally high QoL and tumor control for people with prostate cancer,...

Childhood Cancer Survivor Meet: 300 cancer survivors share their inspiring journeys at NRS Medical College

Childhood Cancer Survivor Meet: 300 cancer survivors share their inspiring journeys at NRS Medical...

Sun Pharma

Sun Pharma gets exclusive worldwide rights to commercialize Philogen anti-cancer immunotherapy...

Combination 5-FU/Calcipotriene Cream Shows Promise in Treating Cutaneous Squamous Cell Carcinoma: Study

Combination 5-FU/Calcipotriene Cream Shows Promise in Treating Cutaneous Squamous Cell Carcinoma:...

View All
X